Titanate particles as agents to deliver gold compounds to fibroblasts and monocytes

Ryan R. Davis, David T. Hobbs, Rania Khashaba, Poojitha Sehkar, Francesca N. Seta, Regina L W Messer, Jill B. Lewis, John C. Wataha

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Titanates are inorganic compounds with high affinity for specific metal ions or metal compounds, including gold. We have previously demonstrated that both monosodium titanate (MST) and amorphous peroxo-titanate (APT) alone do not suppress cellular metabolism of several cell types, and we have shown that MST and APT adsorb and release gold compounds in biological salt solutions. In the current study, we extend this work and show that MST and APT loaded with two gold compounds deliver sufficient levels of these compounds to alter the metabolism of mammalian cells. Fibroblasts (L929) or monocytes (THP1) were exposed to MST and APT loaded with either Au(III) or Auranofin®, a Au(I)-organic compound, for 24-72 h, after which succinate dehydrogenase (SDH) activity of the cells was measured using the MTT method. MST or APT alone did not suppress SDH activity of either cell type. AF and Au(III) alone suppressed SDH activity completely above 2 μM or 300 μM, respectively. APT and MST loaded with either gold compound suppressed L929 fibroblast SDH activity by 30-80% after 72 h, but Au(III)-loaded APT was more potent than AF-loaded APT. Monocyte SDH activity was not affected by any loaded titanate. Our results suggest that titanates could be used for solid phase delivery of metal compounds to affect mammalian cell function of some types of cells.

Original languageEnglish (US)
Pages (from-to)864-869
Number of pages6
JournalJournal of Biomedical Materials Research - Part A
Volume93
Issue number3
DOIs
StatePublished - Jun 1 2010

Fingerprint

Gold compounds
Gold Compounds
Fibroblasts
Monocytes
Succinate Dehydrogenase
Metals
Cells
Metabolism
Auranofin
Inorganic compounds
peroxo-titanate
Organic compounds
Metal ions
Salts
Oxidoreductases
Ions

Keywords

  • Arthritis
  • Auranofin
  • Drug delivery
  • Metals
  • Nanoparticles

ASJC Scopus subject areas

  • Ceramics and Composites
  • Biomaterials
  • Biomedical Engineering
  • Metals and Alloys

Cite this

Titanate particles as agents to deliver gold compounds to fibroblasts and monocytes. / Davis, Ryan R.; Hobbs, David T.; Khashaba, Rania; Sehkar, Poojitha; Seta, Francesca N.; Messer, Regina L W; Lewis, Jill B.; Wataha, John C.

In: Journal of Biomedical Materials Research - Part A, Vol. 93, No. 3, 01.06.2010, p. 864-869.

Research output: Contribution to journalArticle

Davis, RR, Hobbs, DT, Khashaba, R, Sehkar, P, Seta, FN, Messer, RLW, Lewis, JB & Wataha, JC 2010, 'Titanate particles as agents to deliver gold compounds to fibroblasts and monocytes', Journal of Biomedical Materials Research - Part A, vol. 93, no. 3, pp. 864-869. https://doi.org/10.1002/jbm.a.32407
Davis, Ryan R. ; Hobbs, David T. ; Khashaba, Rania ; Sehkar, Poojitha ; Seta, Francesca N. ; Messer, Regina L W ; Lewis, Jill B. ; Wataha, John C. / Titanate particles as agents to deliver gold compounds to fibroblasts and monocytes. In: Journal of Biomedical Materials Research - Part A. 2010 ; Vol. 93, No. 3. pp. 864-869.
@article{a01243f532f74beaa4c39fc03802ec68,
title = "Titanate particles as agents to deliver gold compounds to fibroblasts and monocytes",
abstract = "Titanates are inorganic compounds with high affinity for specific metal ions or metal compounds, including gold. We have previously demonstrated that both monosodium titanate (MST) and amorphous peroxo-titanate (APT) alone do not suppress cellular metabolism of several cell types, and we have shown that MST and APT adsorb and release gold compounds in biological salt solutions. In the current study, we extend this work and show that MST and APT loaded with two gold compounds deliver sufficient levels of these compounds to alter the metabolism of mammalian cells. Fibroblasts (L929) or monocytes (THP1) were exposed to MST and APT loaded with either Au(III) or Auranofin{\circledR}, a Au(I)-organic compound, for 24-72 h, after which succinate dehydrogenase (SDH) activity of the cells was measured using the MTT method. MST or APT alone did not suppress SDH activity of either cell type. AF and Au(III) alone suppressed SDH activity completely above 2 μM or 300 μM, respectively. APT and MST loaded with either gold compound suppressed L929 fibroblast SDH activity by 30-80{\%} after 72 h, but Au(III)-loaded APT was more potent than AF-loaded APT. Monocyte SDH activity was not affected by any loaded titanate. Our results suggest that titanates could be used for solid phase delivery of metal compounds to affect mammalian cell function of some types of cells.",
keywords = "Arthritis, Auranofin, Drug delivery, Metals, Nanoparticles",
author = "Davis, {Ryan R.} and Hobbs, {David T.} and Rania Khashaba and Poojitha Sehkar and Seta, {Francesca N.} and Messer, {Regina L W} and Lewis, {Jill B.} and Wataha, {John C.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1002/jbm.a.32407",
language = "English (US)",
volume = "93",
pages = "864--869",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "0021-9304",
publisher = "Heterocorporation",
number = "3",

}

TY - JOUR

T1 - Titanate particles as agents to deliver gold compounds to fibroblasts and monocytes

AU - Davis, Ryan R.

AU - Hobbs, David T.

AU - Khashaba, Rania

AU - Sehkar, Poojitha

AU - Seta, Francesca N.

AU - Messer, Regina L W

AU - Lewis, Jill B.

AU - Wataha, John C.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Titanates are inorganic compounds with high affinity for specific metal ions or metal compounds, including gold. We have previously demonstrated that both monosodium titanate (MST) and amorphous peroxo-titanate (APT) alone do not suppress cellular metabolism of several cell types, and we have shown that MST and APT adsorb and release gold compounds in biological salt solutions. In the current study, we extend this work and show that MST and APT loaded with two gold compounds deliver sufficient levels of these compounds to alter the metabolism of mammalian cells. Fibroblasts (L929) or monocytes (THP1) were exposed to MST and APT loaded with either Au(III) or Auranofin®, a Au(I)-organic compound, for 24-72 h, after which succinate dehydrogenase (SDH) activity of the cells was measured using the MTT method. MST or APT alone did not suppress SDH activity of either cell type. AF and Au(III) alone suppressed SDH activity completely above 2 μM or 300 μM, respectively. APT and MST loaded with either gold compound suppressed L929 fibroblast SDH activity by 30-80% after 72 h, but Au(III)-loaded APT was more potent than AF-loaded APT. Monocyte SDH activity was not affected by any loaded titanate. Our results suggest that titanates could be used for solid phase delivery of metal compounds to affect mammalian cell function of some types of cells.

AB - Titanates are inorganic compounds with high affinity for specific metal ions or metal compounds, including gold. We have previously demonstrated that both monosodium titanate (MST) and amorphous peroxo-titanate (APT) alone do not suppress cellular metabolism of several cell types, and we have shown that MST and APT adsorb and release gold compounds in biological salt solutions. In the current study, we extend this work and show that MST and APT loaded with two gold compounds deliver sufficient levels of these compounds to alter the metabolism of mammalian cells. Fibroblasts (L929) or monocytes (THP1) were exposed to MST and APT loaded with either Au(III) or Auranofin®, a Au(I)-organic compound, for 24-72 h, after which succinate dehydrogenase (SDH) activity of the cells was measured using the MTT method. MST or APT alone did not suppress SDH activity of either cell type. AF and Au(III) alone suppressed SDH activity completely above 2 μM or 300 μM, respectively. APT and MST loaded with either gold compound suppressed L929 fibroblast SDH activity by 30-80% after 72 h, but Au(III)-loaded APT was more potent than AF-loaded APT. Monocyte SDH activity was not affected by any loaded titanate. Our results suggest that titanates could be used for solid phase delivery of metal compounds to affect mammalian cell function of some types of cells.

KW - Arthritis

KW - Auranofin

KW - Drug delivery

KW - Metals

KW - Nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=77950664634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950664634&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.32407

DO - 10.1002/jbm.a.32407

M3 - Article

C2 - 19701910

AN - SCOPUS:77950664634

VL - 93

SP - 864

EP - 869

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 0021-9304

IS - 3

ER -